10-Q: Petco Q3 2025: Net Income Rebounds Amid Sales Dip

Sentiment:

Quarterly Report


Petco Health and Wellness Company, Inc. reported a return to net income in Q3 2025, reaching $9.3 million, despite a 3.1% decrease in net sales to $1.46 billion.

Capital raiseThe company may seek additional financing to fund future growth or refinance existing indebtedness through the debt capital markets.There is no assurance that such financing will be available on favorable terms, or at all.
Better than expectedNet income for the thirteen weeks ended November 1, 2025, was $9.3 million, a significant improvement from a net loss of $16.7 million in the prior year period.Operating income for the thirteen weeks ended November 1, 2025, increased to $29.2 million from $4.0 million in the prior year period.Adjusted EBITDA for the thirteen weeks ended November 1, 2025, increased to $98.6 million from $81.2 million in the prior year period.Free Cash Flow for the thirty-nine weeks ended November 1, 2025, was positive $70.6 million, compared to a negative $9.4 million in the prior year period.Gross profit rate improved to 38.9% for the thirteen weeks and 38.8% for the thirty-nine weeks, indicating better margin management.SG&A expenses as a percentage of net sales decreased, reflecting improved cost control.

Summary

  • Net sales for the thirteen weeks ended November 1, 2025, decreased by 3.1% to $1.46 billion, with comparable sales down 2.2%.
  • Net sales for the thirty-nine weeks ended November 1, 2025, decreased by 2.6% to $4.45 billion.
  • Operating income for the thirteen weeks increased significantly to $29.2 million from $4.0 million in the prior year period.
  • Net income attributable to Class A and B-1 common stockholders was $9.3 million for the thirteen weeks, a turnaround from a $16.7 million net loss in the prior year.
  • Adjusted EBITDA for the thirteen weeks increased to $98.6 million from $81.2 million, with Adjusted EBITDA Margin improving to 6.7% from 5.4%.
  • Net cash provided by operating activities for the thirty-nine weeks increased to $160.5 million from $81.7 million.
  • Free Cash Flow for the thirty-nine weeks improved to $70.6 million from a negative $9.4 million in the prior year.
  • Gross profit rate improved to 38.9% for the thirteen weeks and 38.8% for the thirty-nine weeks, up from 38.1% and 38.0% respectively.
  • SG&A expenses as a percentage of net sales decreased to 36.9% for the thirteen weeks and 36.8% for the thirty-nine weeks.
  • Total pet care centers (U.S. and Puerto Rico) decreased to 1,389 at November 1, 2025, from 1,413 at November 2, 2024.

Sentiment

Score: 7

Explanation: While sales declined, the company demonstrated strong improvements in profitability metrics (net income, operating income, Adjusted EBITDA) and cash flow (Free Cash Flow), indicating effective cost management and strategic adjustments. The corporate governance updates are positive for transparency and efficiency. The sales decline and macroeconomic risks temper the overall sentiment, but the financial turnaround is a strong positive.

Positives

  • Return to net income of $9.3 million for the thirteen weeks, compared to a $16.7 million net loss in the prior year.
  • Significant increase in operating income to $29.2 million for the thirteen weeks, up from $4.0 million.
  • Adjusted EBITDA increased to $98.6 million for the thirteen weeks, up from $81.2 million, indicating improved operational efficiency.
  • Gross profit rate improved to 38.9% for the thirteen weeks and 38.8% for the thirty-nine weeks, driven by better services utilization and inventory/pricing management.
  • SG&A expenses decreased as a percentage of net sales, primarily due to lower payroll, compensation costs, and consulting fees.
  • Net cash provided by operating activities for the thirty-nine weeks nearly doubled to $160.5 million.
  • Free Cash Flow for the thirty-nine weeks turned positive at $70.6 million, from a negative $9.4 million.
  • Interest expense decreased due to lower interest rates on the First Lien Term Loan.
  • Momentum in services, driven by strategic investments in customer acquisition and retention, and optimizing veterinary hospital footprint.

Negatives

  • Total net sales decreased by 3.1% for the thirteen weeks and 2.6% for the thirty-nine weeks.
  • Comparable sales decreased by 2.2% for the thirteen weeks and 1.6% for the thirty-nine weeks.
  • Sales decrease primarily reflects lower transaction volume and a lower pet care center count.
  • Lower sales partially offset the increase in operating cash flows.
  • Higher payouts of prior year accrued incentive bonuses partially offset the increase in operating cash flows.

Risks

  • Increased competition from multi-channel retailers, mass and grocery retailers, and e-Commerce providers.
  • Reduced consumer demand for products and/or services.
  • Reliance on key vendors.
  • Ability to attract and retain qualified employees.
  • Risks arising from statutory, regulatory, and/or legal developments.
  • Macroeconomic pressures, including inflation, prevailing interest rates, and the impact of tariffs.
  • Failure to effectively manage costs.
  • Reliance on information technology systems.
  • Ability to prevent or effectively respond to a data privacy or security breach.
  • Ability to effectively manage or integrate strategic ventures, alliances, or acquisitions and realize anticipated benefits.
  • Economic or regulatory developments affecting ability to provide attractive promotional financing.
  • Business interruptions and other supply chain issues.
  • Catastrophic events, political tensions, conflicts and wars (e.g., Ukraine, Middle East), health crises, and pandemics.
  • Ability to maintain positive brand perception and recognition.
  • Product safety and quality concerns.
  • Changes to labor or employment laws or regulations.
  • Ability to effectively manage real estate portfolio.
  • Constraints in the capital markets or vendor credit terms.
  • Changes in credit ratings.
  • Impairments of goodwill and other intangible assets.
  • Ability to successfully implement operational adjustments, achieve expected benefits of cost action plans, and drive improved profitability.
  • Legal proceedings and other claims and litigation arising in the ordinary course of business, with inherently uncertain outcomes.

Future Outlook

The company expects to continue its growth plans, compete effectively, execute transformation initiatives, and manage the impact of macroeconomic factors such as tariffs, inflationary and interest rate pressures, consumer spending patterns, global supply chain constraints, and global economic and geopolitical developments. It also aims to improve comparable sales through initiatives focused on customer retention, visit frequency, and basket size.

Management Comments

  • We continue to experience momentum in services, driven in part by our strategic investments in customer acquisition and retention, as well as efforts to optimize our existing veterinary hospital footprint.
  • We believe that our current resources, together with anticipated cash flows from operations and borrowing capacity under the ABL Revolving Credit Facility will be sufficient to finance our operations, meet our current cash requirements, and fund anticipated capital investments for at least the next 12 months.

Industry Context

The pet specialty retail industry faces ongoing challenges from increased competition across various channels, including multi-channel, mass, grocery, and e-commerce retailers. Petco's strategy to focus on services and optimize its veterinary hospital footprint aligns with a broader industry trend towards integrated pet care solutions, aiming to differentiate from product-only competitors and capture a larger share of recurring customer spend. The macroeconomic pressures, including inflation and changing consumer spending patterns, are impacting the entire retail sector, making disciplined cost management and strategic pricing crucial for profitability.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Bylaws AmendmentBoard of Directors approved and adopted the Third Amended and Restated Bylaws, effective December 2, 2025. Changes include clarifying notice procedures for virtual stockholder meetings, eliminating the requirement for stockholder list examination at meetings (per 2022 DGCL amendments), updating director nomination procedures for stockholders (Rule 14a-19 Exchange Act), requiring non-white proxy cards for soliciting stockholders, and requiring a quorum not to be readily convened for emergency bylaws to operate.2025-12-02Enhances corporate governance by aligning with new SEC rules and Delaware law, improving clarity and efficiency for stockholder meetings and director nominations, and standardizing proxy solicitation practices. The changes aim to streamline processes and ensure compliance with evolving regulatory landscapes.

Legal Proceedings

  • The company is involved in legal proceedings and subject to other claims and litigation arising in the ordinary course of business.
  • Accruals have been made where appropriate, but these are not considered individually or in aggregate material.
  • Management does not currently expect these matters to have a material adverse effect on consolidated financial statements, but outcomes are inherently uncertain.

Stakeholder Impact

  • Shareholders: Positive impact from the return to net income, improved operating income, and positive free cash flow, potentially leading to increased shareholder value. Corporate governance updates enhance transparency and shareholder rights regarding nominations.
  • Employees: Lower payroll and compensation costs, including improved actuarial results from employee benefits optimization initiatives, could imply some adjustments, but also a focus on efficiency. Equity-based compensation continues.
  • Customers: Continued strategic investments in customer acquisition and retention, and optimization of veterinary hospital footprint, suggest ongoing efforts to enhance customer experience and service offerings.
  • Creditors: Compliance with debt covenants and sufficient liquidity for the next 12 months are positive for creditors. Lower interest expense also benefits the company's ability to service debt.
  • Suppliers: Decreased inventory purchases could impact suppliers, but the focus on disciplined unit costs and inventory management aims for overall business health.

Next Steps

  • Continue initiatives to increase customer retention, frequency of visits, and basket size to improve comparable sales.
  • Manage unit costs, pricing, and promotional strategies with a disciplined approach to focus on profitability and margin.
  • Optimize existing veterinary hospital footprint.
  • Potentially seek additional financing to fund future growth or refinance existing indebtedness.

Key Dates

DateDescription
2022-11Company entered into interest rate cap agreements.
2022-12-30Interest rate caps became effective.
2024-03Company amended the ABL Revolving Credit Facility to increase availability and extend maturity.
2024-12-31Interest rate caps expired.
2025-01-01Immediate expensing of domestic research and experimental expenditures starts per OBBBA.
2025-01-19100 percent bonus depreciation for qualified property placed in service after this date per OBBBA.
2025-07-04The One Big Beautiful Bill Act (OBBBA) was signed into law.
2025-11-01End of the quarterly period covered by this report.
2025-12-02Board of Directors approved and adopted the Third Amended and Restated Bylaws, effective immediately.
2025-12-03Date for shares outstanding count.
2025-12-05Date of filing of this Quarterly Report on Form 10-Q.
2026-03-04Maturity date of the first tranche of the ABL Revolving Credit Facility.
2028-03-04Maturity date of the First Lien Term Loan.
2029-03-29Maturity date of the second tranche of the ABL Revolving Credit Facility.

Recommendation

hold

While Petco demonstrated a strong financial turnaround with a return to net income, improved operating income, and positive free cash flow, the persistent decline in net sales and comparable sales remains a concern. The company's strategic focus on services and cost management is yielding results in profitability, but the top-line weakness suggests ongoing challenges in consumer demand and competitive pressures. The improved liquidity and compliance with debt covenants are positive, but the overall picture warrants a 'hold' as investors assess whether the profitability improvements can be sustained and eventually translate into sales growth.

Keywords

Petco, WOOF, Quarterly Report, 10-Q, Financial Results, Net Sales, Operating Income, Net Income, Adjusted EBITDA, Free Cash Flow, Pet Care, Retail, Services, Omnichannel, Corporate Governance, Bylaws, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.